CDNA $21.75 0.12 (0.6%)

    CDNA Profile

    CDNA trades on the NASDAQ.

    MEMBERSHIP
    --
    SECTOR
    Health Care
    MARKET CAPITALIZATION

    $930 Million

    CareDx Inc operates as a transplant diagnostics company, which offers pre- and post-transplant continuum. The company focuses on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic surveillance solutions for transplant patients. Its product includes AlloMap, which aids clinicians in identifying heart transplant recipients with stable allograft function and AlloSure, which is a donor-derived cell free DNA test.

    CDNA Earnings

    EPS

    -0.04

    P/E

    --

    Q2 Earnings for Apr, May & Jun

    Thu, Aug 1, 2019

    Since Earnings Report

    CDNA -33.6%

    Q3 Earnings for Jul, Aug & Sep

    Thu, Oct 31, 2019

    Since Earnings Report

    CDNA -16.9%

    CDNA Dividend

    Dividend Yield

    0.00%

    Dividend Rate

    $0.00

    Ex-Dividend Date

    --

    Dividend Pay Date

    --

    Dividend Frequency

    --

    Dividend Payments

    --

    CDNA Charts

    52WL $18.75
    52WH $41.27
    All-Time $41.27


    CDNA Industry Competitors


    MEDICAL DIAGNOSTICS & RESEARCH
    Koninklijke Philips N.V. NY Registry Shares
    DexCom
    Exact Sciences
    Bio-Rad Laboratories Inc
    Qiagen NV
    Icon PLC
    Bruker Corp
    Guardant Health Inc
    Charles River Laboratories International Inc
    PRA Health Sciences Inc



    Symbol MC DY Price Day YTD
    CDNA $0.93 0.00% $21.75 -0.6% -9.3%






        TOP    




    info@symbolsurfing.com


    Symbol Surfing

    ©2019 Symbol Surfing All Rights Reserved.

    Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

    Cookies Policy Terms Of Service Privacy Policy